查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595361

色素失調治療市場：按適應症、治療方法、最終用戶分類 - 2025-2030 年全球預測

Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年色素障礙治療市值為67.8億美元，預計2024年將達到72.8億美元，複合年成長率為7.42%，到2030年將達到112.1億美元。

色素失調治療市場包括旨在糾正因黑色素生成過多、荷爾蒙失衡和遺傳條件等因素引起的膚色異常的治療方法和解決方案。由於人們對美麗肌膚的需求不斷增加，以及黃褐斑、白斑症和色素沉著等色素沉著疾病的日益流行，這個市場的需求龐大。應用包括局部藥膏、雷射治療、化學換膚和藥物干預，主要由皮膚科醫生和美容診所使用。最終用途範圍涵蓋醫療設施和專注於美容和健康的直接面對消費者的護膚品牌。

主要市場統計
基準年[2023] 67.8億美元
預測年份 [2024] 72.8億美元
預測年份 [2030] 112.1億美元
複合年成長率（%） 7.42%

市場成長是由皮膚病學技術的進步和消費者對皮膚健康意識的提高所推動的。新興國家可支配收入的增加和對自我護理的日益偏好導致更多的治療方案被採用。此外，開拓更有效、侵入性更小的治療方法代表了市場擴張的重大機會。然而，高昂的費用、缺乏全民保險覆蓋以及先進治療的潛在副作用等限制帶來了挑戰。此外，市場分散，產品供應和患者獲得治療的機會存在地區差異。

為了利用成長機會，我們需要投資下一代治療方法，以最大限度地減少副作用並更快地獲得結果，例如基因療法和生物工程皮膚治療。加強對個人化和種族客製化治療方法的研究也將推動市場主導。這個市場的本質是競爭性的，其特點是不斷的技術創新、監管監督和快速的技術進步。有效的市場策略應著重策略聯盟、併購，以加強研發能力。針對年輕人的創新行銷和數位健康平台的使用也有可能提高消費者參與度並擴大市場覆蓋範圍。

市場動態：快速發展的色素紊亂治療市場的關鍵市場洞察

供需的動態交互作用正在改變色素障礙治療市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 人們對護膚重要性的認知和興趣不斷增強
    • 化妝品和護膚品支出增加
    • 研發費用增加和積極的行銷策略
  • 市場限制因素
    • 治療費用上漲和治療結果差異
  • 市場機會
    • 雷射治療和針刺工藝等技術的進步
    • 壬二酸等多種藥物的進展
  • 市場挑戰
    • 皮膚敏感增加、過敏、對某些藥物的反應

波特的五力：駕馭色素紊亂治療市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解色素紊亂治療市場的外部影響

外部宏觀環境因素在塑造色素障礙治療市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解色素障礙治療市場的競爭狀況

對色素紊亂治療市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位基質色素紊亂治療市場供應商的績效評估

FPNV定位矩陣是評估色素障礙治療市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了色素障礙治療市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，色素紊亂治療市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人們對護膚重要性的認知和興趣不斷增強
      • 化妝品和護膚品支出增加
      • 研發費用增加和積極的行銷策略
    • 抑制因素
      • 治療費用高且結果各異。
    • 機會
      • 雷射治療和針刺工藝等技術進步
      • 壬二酸等多種藥物的進展
    • 任務
      • 皮膚敏感、過敏和對某些物質的反應增加
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章依適應症分類的色素失調治療市場

  • 色素沉著
  • 色素沉澱不足

第7章色素紊亂治療市場治療與療法

  • 化學換膚
  • 皮膚脫皮
  • 表面置換
  • 黃褐斑

第8章色素失調治療市場：依最終使用者分類

  • 皮膚科診所
  • 醫院

第9章北美與南美色素失調治療市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太色素失調治療市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲/中東/非洲色素障礙治療市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Affiliated Dermatology
  • Allergan, Inc.
  • Derma Med Spa
  • EpiPharm AG
  • GK Dermatology, PC
  • Kaya Limited
  • La Roche-Posay by L'Oreal Singapore Pte. Ltd.
  • Obagi Cosmeceuticals LLC
  • Skin Deep Laser Services
  • VIVIER PHARMA USA
  • Water's Edge Dermatology
Product Code: MRR-030EE4851634

The Pigmentation Disorders Treatment Market was valued at USD 6.78 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.42%, to USD 11.21 billion by 2030.

The Pigmentation Disorders Treatment market encompasses therapies and solutions aimed at correcting abnormalities in skin coloration caused by factors such as melanin overproduction, hormonal imbalances, or genetic conditions. This market holds significant necessity due to the growing demand for aesthetically pleasing skin and the increasing prevalence of pigmentation disorders like melasma, vitiligo, and hyperpigmentation. Applications include topical ointments, laser therapies, chemical peels, and pharmaceutical interventions primarily used by dermatologists and cosmetic clinics. The end-use scope extends to both medical facilities and direct consumer skincare brands focused on beauty and wellness.

KEY MARKET STATISTICS
Base Year [2023] USD 6.78 billion
Estimated Year [2024] USD 7.28 billion
Forecast Year [2030] USD 11.21 billion
CAGR (%) 7.42%

Market growth is bolstered by advancements in dermatological technology and increasing consumer awareness about skin health. Rising disposable incomes in emerging economies and a trend towards self-care are leading to greater adoption rates of treatment options. Moreover, the development of more effective, less invasive treatments offers substantial opportunities for market expansion. However, limitations such as the high cost of advanced treatments, a lack of universal insurance coverage, and the potential for side effects pose challenges. Further, the market is fragmented with regional variances in product availability and patient access to treatments.

To capitalize on growth opportunities, businesses should invest in next-generation therapies that minimize side effects and offer faster results, such as gene therapy and bioengineered skin treatments. Enhancing research into personalized and ethnically-tailored treatment regimens can also drive market leadership. The nature of this market is competitive, characterized by continuous innovation, regulatory scrutiny, and a fast pace of technological advancements. Effective market strategies should focus on strategic partnerships, mergers, and acquisitions to bolster research and development capabilities. Innovative marketing targeting younger demographics and leveraging digital health platforms could also enhance consumer engagement and broaden market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness and concerns about importance of skincare
    • Growing expenditure on cosmetics and skincare products
    • Rising R&D spending and aggressive marketing strategies
  • Market Restraints
    • High cost of treatments and varying output results
  • Market Opportunities
    • Technological advancements like laser treatment and needling process
    • Advancements in various drugs like azelaic acid
  • Market Challenges
    • Increasing skin sensitivity, allergies and reactions to some

Porter's Five Forces: A Strategic Tool for Navigating the Pigmentation Disorders Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pigmentation Disorders Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pigmentation Disorders Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pigmentation Disorders Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pigmentation Disorders Treatment Market

A detailed market share analysis in the Pigmentation Disorders Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pigmentation Disorders Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pigmentation Disorders Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pigmentation Disorders Treatment Market

A strategic analysis of the Pigmentation Disorders Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Affiliated Dermatology, Allergan, Inc., Derma Med Spa, EpiPharm AG, GK Dermatology, PC, Kaya Limited, La Roche-Posay by L'Oreal Singapore Pte. Ltd., Obagi Cosmeceuticals LLC, Skin Deep Laser Services, VIVIER PHARMA USA, and Water's Edge Dermatology.

Market Segmentation & Coverage

This research report categorizes the Pigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Hyperpigmentation and Hypopigmentation.
  • Based on Treatment & Therapies, market is studied across Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma.
  • Based on End User, market is studied across Dermatology Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness and concerns about importance of skincare
      • 5.1.1.2. Growing expenditure on cosmetics and skincare products
      • 5.1.1.3. Rising R&D spending and aggressive marketing strategies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and varying output results
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements like laser treatment and needling process
      • 5.1.3.2. Advancements in various drugs like azelaic acid
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pigmentation Disorders Treatment Market, by Indication

  • 6.1. Introduction
  • 6.2. Hyperpigmentation
  • 6.3. Hypopigmentation

7. Pigmentation Disorders Treatment Market, by Treatment & Therapies

  • 7.1. Introduction
  • 7.2. Chemical Peels
  • 7.3. Dermabrasion
  • 7.4. Laser Resurfacing
  • 7.5. Melasma

8. Pigmentation Disorders Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Dermatology Clinics
  • 8.3. Hospitals

9. Americas Pigmentation Disorders Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pigmentation Disorders Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pigmentation Disorders Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Affiliated Dermatology
  • 2. Allergan, Inc.
  • 3. Derma Med Spa
  • 4. EpiPharm AG
  • 5. GK Dermatology, PC
  • 6. Kaya Limited
  • 7. La Roche-Posay by L'Oreal Singapore Pte. Ltd.
  • 8. Obagi Cosmeceuticals LLC
  • 9. Skin Deep Laser Services
  • 10. VIVIER PHARMA USA
  • 11. Water's Edge Dermatology

LIST OF FIGURES

  • FIGURE 1. PIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPOPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMABRASION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER RESURFACING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023